Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations

Human Molecular Genetics

Volumn 13, Issue 16, 2004, Pages 1715-1725

  Li, Jing ^a   Moran, Thomas ^a   Swanson, Eric ^a   Julian, Christina ^a   Harris, Jeremy ^a   Bonen, Denise K ^a   Hedl, Matija ^a   Nicolae, Dan L ^a   Abraham, Clara ^a   Cho, Judy H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUCINE; MESSENGER RNA; MURAMYL DIPEPTIDE; PEPTIDOGLYCAN; PROTEIN P50; PROTEIN SUBUNIT; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNITY; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MICROARRAY; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WILD TYPE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; CROHN DISEASE; CYTOKINES; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MICROARRAY ANALYSIS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444332518     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh182     Document Type: Article

References (48)

1. Podolsky, D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med., 347, 417-429.
2. Loftus, E.V., Jr, Silverstein, M.D., Sandborn, W.J., Tremaine, W.J., Harmsen, W.S. and Zinsmeister, A.R. (1998) Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology, 114, 1161-1168.
3. Loftus, E.V., Jr and Sandborn, W.J. (2002) Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am., 31, 1-20.
4. Bonen, D.K. and Cho, J.H. (2003) The genetics of inflammatory bowel disease. Gastroenterology, 124, 521-536.
5. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
6. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
7. Cavanaugh, J.A., Adams, K.E., Quak, E.J., Bryce, M.E., O'Callaghan, N.J., Rodgers, H.J., Magarry, G.R., Butler, W.J., Eaden, J.A., Roberts-Thomson, I.C. et al. (2003) CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann. Hum. Genet., 67, 35-41.
8. Cuthbert, A.P., Fisher, S.A., Mirza, M.M., King, K., Hampe, J., Croucher, P.J., Mascheretti, S., Sanderson, J., Forbes, A., Mansfield, J. et al. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology, 122, 867-874.
9. Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., Nunez, G. and Fernandez-Luna, J.L. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelia[ cells via nuclear factor-kappa B activation. J. Biol. Chem., 277, 41701-41705.
10. Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. and Nunez, G. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem., 276, 4812-4818.
11. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M. et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem., 278, 5509-5512.
12. Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. and Sansonetti, P.J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem., 278, 8869-8872.
13. Inohara, N., del Peso, L., Koseki, T., Chen, S. and Nunez, G. (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem., 273, 12296-12300.
14. Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R., Merino, J., Liu, D., Ni, J. et al. (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem., 274, 14560-14567.
15. Bonen, D.K., Ogura, Y., Nicolae, D.L., Inohara, N., Saab, L., Tanabe, T., Chen, F.F., Foster, S.J., Duerr, R.H., Brant, S.R. et al. (2003) Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology, 124, 140-146.
16. Chamaillard, M., Philpott, D., Girardin, S.E., Zouali, H., Lesage, S., Chareyre, F., Bui, T.H., Giovannini, M., Zaehringer, U., Penard-Lacronique. V. et al. (2003) Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl Acad. Sci. USA, 100, 3455-3460.
17. Mitsuyama, K., Toyonaga, A., Sasaki, E., Watanabe, K., Tateishi, H., Nishiyama, T., Saiki, T., Ikeda, H., Tsuruta, O. and Tanikawa, K. (1994) IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin. Exp. Immunol., 96, 432-436.
18. Standiford, T.J., Kunkel, S.L., Basha, M.A., Chensue, S.W., Lynch, J.P., 3rd, Toews, G.B., Westwick, J. and Stricter, R.M. (1990) Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest., 86, 1945-1953.
19. Yoshimura, T., Matsushima, K., Oppenheim, J.J. and Leonard, E.J. (1987) Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J. Immunol., 139, 788-793.
20. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T. and Akira, S. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. USA, 90, 10193-10197.
21. Lorenz, J.J., Furdon, P.J., Taylor, J.D., Verghese, M.W., Chandra, G., Kost, T.A., Haneline, S.A., Roner, L.A. and Gray, J.G. (1995) A cyclic adenosine 3′,5′-monophosphate signal is required for the induction of IL-1 beta by TNF-alpha in human monocytes. J. Immunol., 155, 836-844.
22. Sirenko, O.I., Lofquist, A.K., DeMaria, C.T., Morris, J.S., Brewer, G. and Haskill, J.S. (1997) Adhesion-dependent regulation of an A+U-rich element-binding activity associated with AUF1. Mol. Cell. Biol., 17, 3898-3906.
23. Gu, Y., Wu, J., Faucheu, C., Lalanne, J.L., Diu, A., Livingston, D.J. and Su, M.S. (1995) Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J., 14, 1923-1931.
24. Wilson, K.P., Black, J.A., Thomson, J.A., Kim, E.E., Griffith, J.P., Navia, M.A., Murcko, M.A., Chambers, S.P., Aldape, R.A., Raybuck, S.A. et al. (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature, 370, 270-275.
25. Howard, A.D., Kostura, M.J., Thornberry, N., Ding, G.J., Limjuco, G., Weidner, J., Salley, J.P., Hogquist, K.A., Chaplin, D.D., Mumford, R.A. et al. (1991) IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J. Immunol. (Baltimore), 147, 2964-2969.
26. Cerretti, D.P., Kozlosky, C.J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.A., March, C.J., Kronheim, S.R., Druck, T., Cannizzaro, L.A. et al. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science, 256, 97-100.
27. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J. et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature, 356, 768-774.
28. Nau, G.J., Richmond, J.F., Schlesinger, A., Jennings, E.G., Lander, E.S. and Young, R.A. (2002) Human macrophage activation programs induced by bacterial pathogens. Proc. Natl Acad. Sci. USA, 99, 1503-1508.
29. Vidal, V.F., Casteran, N., Riendeau, C.J., Kornfeld, H., Darcissac, E.C., Capron, A. and Bahr, G.M. (2001) Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and toll-like receptors 2 and 4. Eur. J. Immunol., 31, 1962-1971.
30. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K. and Akira, S. (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity, 8, 383-390.
31. Morelli, A.E., Zahorchak, A.F., Larregina, A.T., Colvin, B.L., Logar, A.J., Takayama, T., Falo, L.D. and Thomson, A.W. (2001) Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood, 98, 1512-1523.
32. Toms, C. and Powrie, F. (2001) Control of intestinal inflammation by regulatory T cells. Microbes Infect., 3, 929-935.
33. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle. Cell, 109 (suppl.), S81-S96.
34. Pauleau, A.L. and Murray, P.J. (2003) Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell. Biol., 23, 7531-7539.
35. Rehli, M. (2002) Of mice and men: species variations of toll-like receptor expression. Trends Immunol., 23, 375-378.
36. Wang, J., Guan, E., Roderiquez, G. and Norcross, M.A. (1999) Inhibition of CCRS expression by IL-12 through induction of beta-chemokines in human T lymphocytes. J. Immunol., 163, 5763-5769.
37. Ranade, K., Jorgenson, E., Sheu, W.H., Pei, D., Hsiung, C.A., Chiang, F.T., Chen, Y.D., Pratt, R., Olshen, R.A., Curb, D. et al. (2002) A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am. J. Hum. Genet., 70, 935-942.
38. Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J.L., Mattmann, C. and Tschopp, J. (1998) Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol., 8, 885-888.
39. Zhang, W.H., Wang, X., Narayanan, M., Zhang, Y., Huo, C., Reed, J.C. and Friedlander, R.M. (2003) Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc. Natl Acad. Sci. USA, 100, 16012-16017.
40. Yoo, N.J., Park, W.S., Kim, S.Y., Reed, J.C., Son, S.G., Lee, J.Y. and Lee, S.H. (2002) Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun., 299, 652-658.
41. Stehlik, C., Hayashi, H., Pio, F., Godzik, A. and Reed, J.C. (2003) CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. J. Biol. Chem., 278, 31 941-31 949.
42. Korzenik, J.R. and Dieckgraefe, B.K. (2000) Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig. Dis. Sci., 45, 1121-1129.
43. Worsaae, N., Staehr Johansen, K. and Christensen, K.C. (1982) Impaired in vitro function of neutrophils in Crohn's disease. Scand. J. Gastroenterol., 17, 91-96.
44. Wandall, J.H. and Binder, V. (1982) Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro. Gut, 23, 173-180.
45. Erdman, S., Fox, J.G., Dangler, C.A., Feldman, D. and Horwitz, B.H. (2001) Typhlocolitis in NF-kappa B-deficient mice. J. Immunol., 166, 1443-1447.
46. Tomczak, M.F., Erdman, S.E., Poutahidis, T., Rogers, A.B., Holcombe, H., Plank, B., Fox, J.G. and Horwitz, B.H. (2003) NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J. Immunol., 171, 1484-1492.
47. Hofer, S., Rescigno, M., Granucci, F., Citterio, S., Francolini, M. and Ricciardi-Castagnoli, P. (2001) Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide. Microbes Infect., 3, 259-265.
48. Lesage, S., Zouali, H., Cezard, J.P., Colombel, J.F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V. et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet., 70, 845-857.